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1. Introduction
  Ovarian cancer is a women tumor with high malignant 
degree, its five-year survival rate was less than 30%. The 
poor survival rate of ovarian cancer was mainly due to the 
lack of effective screening methods and the early patients 
were without obvious symptoms. Once diagnosed, patients 
were already in advanced stage[1]. The CA125 was lack of 
sensitivity and specificity, which is not a good indicator. It 
is found in recent years that human epididymis-specific 
protein 4 (HE4, encoded by WFDC2 gene) will be a promising 
new markers of ovarian cancer[2], which is important in the 
diagnosis[3], monitoring[4] and prognosis[5] of the ovarian 
cancer. This new diagnostic indicators combined with 
CA125 constitute the ROMA index, which helps to assess 
the risk of ovarian epithelial cell carcinoma of women with 
a pelvic mass pre-menopausal/post-menopausal. Studies 
have shown that the HE4 were with high expression in 
ovarian serous adenocarcinoma, and with weak expression 
in benign ovarian tumors and endometriosis[6]. Hereby, we 
speculated that HE4 gene might plays an important role 
in the occurring and developing of the ovarian cancer. So 
Objective: To investigate effect and possible mechanisms of silencing human WFDC2 (HE4) 
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clarifying WFDC2 gene function may help us to identify a 
new therapeutic target in ovarian cancer. Unfortunately, the 
function of WDC2 gene in ovarian cancer is unclear then.
  Some short fragment of double-stranded RNA can promote 
specific gene mRNA degradation to specifically blocking 
gene expression in vivo, and induce cells exhibit specific 
gene deletion phenotype, which was called RNA interference 
(RNAi)[7]. The landmark discovery of RNAi can specifically 
inhibit the expression of the target gene. In order to explore 
the function of WFDC2 gene in human serous ovarian 
carcinoma, we apply lentiviral small interfering specific to 
inhibit the WFDC2 gene expression in human serous ovarian 
carcinoma cell line SKOV3, and observed the change of 
biological characteristics as cell proliferation, apoptosis, cell 
cycle and ability of invasion and migration. 
2. Materials and methods
2.1. Materials
  Human serous ovarian cancer cell line SKOV3 was provide 
by Cells Center of the Peking University Health Science 
Center; siRNA fragments and control fragment and the 
lentiviral vector pLKO.1 were provided by the Beijing 
Qianjing Kechuang Biotechnology Co., Ltd.; HE4 mouse 
anti-human antibodies were purchased from Abcam; Human 
HE4 primers were purchased from Invitrogen; Restriction 
endonuclease Age 栺(ACCGGT) and EcoR, the small amount 
plasmid extraction kit Gel Extraction kit were purchased 
from TianGen; The packaging virus were purchased from the 
Beijing prospects Kechuang. Age 栺 (NEB, #R0552S), EcoR栺 
(NEB, #R0101S), buffer 2 (NEB, #B7002S), solution 栺 (Takara, 
D6022), agarose gel purified extraction kit (QIAGEN, # 28704), 
1.5 mL microfuge tube (Biologix, Item No: 80-1500).
2.2. siRNA design, primer design and synthesis
  According to the nucleotide sequence (NM_006103.3) of the 
GenBank human HE4 ,siRNA sequence (5’-3’) 004: 8 strips 
were designed for the target, the 5th and 8th were proved 
effective, the above siRNA sequences were synthesized by 
Invitrogen.
2.3. Serous ovarian cancer cell line SKOV3 culture, passage 
and cryopreservation
  Cell lines were cultivated in the condition of 10% FBS 1640 
medium, at 37 曟, 5% CO2. The medium was changed every 
2 d, when 85% cells were fused, replated at 1: 3 after 0.25% 
trypsinization was done. Cells were suspended in medium 
containing 10% DMSO, gradient cryopreservation. HEK293T 
cells were incubator in DMEM high glucose medium 
containing 10% FBS at 37 曟, 5% CO2 .
2.4. Preparation of lentivirus
  293T cell were seeded in 60 mm dishes with the density of 
7×105/60 mm, and seeded on 60 mm plate with the density of 
7×105/60 mm, transfected plasmids after 24 h. The plasmid 
pMD2G and psPAX2 (purchased from addgene company) 
1 毺g, containing knockdown sequence plko plasmid 
2 毺g. Transfection reagent 293 Fect 8 毺L. Change 5 mL 
fresh medium after 12-15 h, collected supernatants after 
24 h, thus obtained the virus solution.
2.5. siRNA fragments transfection
  Passage 2 and 3 cells were taken in this experiment, they 
were seeded in 24-well plates with 2×104/well, and were 
replaced with 60, 50, 120 nmol /L terminal concentration 
transfected interference or control siRNA after 24 h; Then 
cultivated into complete medium after 8 h, and the cells 
were collected after 48 h of incubation.
2.6. Lentiviral infection and stable cell line obtaining
  24 h before infection, the SKOV3 cells were inoculated 
into 60 mm dishes with inoculum density of 5×105 cells/
plate. Next day, lentivirus supernatant that carrying different 
interference sequence was added, and simultaneously added 
Polybrene with final concentration of 8 毺g/mL. 6 h after 
infection, removal viral supernatant and exchange for fresh 
medium, then transferred to 10 cm plate after cultured for  24 
h. After cell attachment, replace to fresh medium puromycin 
with terminal concentration of 1 毺g/mL. Observed after two 
days, control cells not infected with the virus have all died. 
Puromycin resistant cells were contain HE4 interference 
sequence now. Collected some cells, extracted the proteins, 
and use immune blotting to analysis HE4 knock down cell 
lines.
2.7.  Western-blot identification
  1 × SDS sample loading buffer [62 mmol/L Tris-HCl (pH6. 
8), 2% SDS, 10% glycerol, 50 mmol/L of DTT, 1% bromophenol 
blue] were used to collect cells of the interference group or 
control group respectively, 4 曟 ultrasonication, boiled at 
100 曟 for 5 min, centrifuged (15 000 g, 5 min), prepared for 
electrophoresis or stored at -20 曟. Quantitative analysis of 
the protein to weight was performed by Bradford method, 
examined by SDS-PAGE with the amount of 40 毺g protein 
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samples. The target protein were made using 6% separating 
gel and 4% stacking gel, beta-actin was used as the internal 
control with 8% separating gel. Transmembrane and 
blocking, incubated in first antibody and second antibody 
after rinsing, each sample was repeated for 3 times.
2.8. Indexes and methods
2.8.1. Detection of proliferation and apoptosis of SKOV3
  Cell proliferation was measured by MTT cell growth curve: 
The cells were seeded in 96 plates, 1×104 cells for each hole. 
There were 6 parallel holes for each cell, added MTT 20 毺L/hole
after 24 h, incubated for 4 h at 37曟, 5% CO2. The supernatant 
were abandoned, then DMSO 150 毺L/hole was added. 
The OD value of each group was detected at the 490 nm 
wavelength by enzyme immunoassay instrument, the cell 
growth curve was drawn for 5 d. Apoptosis: Flow cytometry 
Annexin V-FITC / PI double labeling were analyzed using 
flow cytometry (BD FACS Calibur). The cells were collected, 
centrifuged, and washed 3 times with PBS, 10 毺L Annexin 
and FITC were added, gently mixed, 5 毺L PI was added. 
Samples were reacted at room temperature for 15 min 
avoiding light. The apoptosis proportion of SKOV3 mock 
transferred to empty vector was used as a control. Annexin 
V+/PI- stained cells (quadrant LR, low right area) represent 
early apoptotic cells. Annexin V+/PI+ stained cells (quadrant 
UR, up right area) represent either late apoptotic cells or 
necrotic cells. 
2.8.2. Assays of cell invasion /migration 
  24 holes with pore diameter 8 毺m and transwell with 
diameter 6.5 mm were used to mimick a cell interaction 
model, the bottom of the upper chamber of the membrane 
were coated with Matrigel in advance to simulate the 
basement membrane and extracellular matrix. Steps: the 
cell were starved for 24 h, the Matrigel were melted and put 
at 4 曟 refrigerator overnight the day before this experiment. 
The pipette tip was pre-cooled in ice-cold for 0.5 h during 
experiment, and the ECM gel was diluted by 1:9 with serum 
free 1640 (dilute to 1 mg/mL), Matrigel 100 毺L was added 
to each well, the whole process was performed on ice. Then 
they were placed in an incubator at 37 曟 for 5 h, thus the 
Matrigel were from liquid form into gelatum. Hydration of 
basement membrane: The residual liquid was aspirated 
from the small chamber, 70 毺L serum free 1640 was added 
in each well at 37 曟 for 30 min,then the m edium was 
removed. 105/mL SKOV3 cells in logarithmic growth phase 
was added in each well for 200 毺L, 500 毺L 1640 medium 
supplemented with 10% fetal bovine serum were added in 
the lower chamber. After culturing for 24 h, nutrient solution 
was abandoned and a cotton swab was used to gently wipe 
out the upper layer of transwell. Membrane of transwell was 
fixed with methanol for 20 min, washed with PBS 3 times, 
then staining with 0.1% crystal violet for 20 min after airing. 
For SKOV3 migration ability measurement, the procedure of 
invasion experimental was the same without Matrigel. After 
washing, the blue-violet cytoplasm can be clearly observed 
under microscopic. The invasive cell numbers of 5 fields 
(upper and lower, left and right, middle) were counted under 
microscope, the mean value was obtained and the statistical 
analysis was made. 
2.9. Statistical analysis
  Data was expressed as mean依SD values, and compared 
with single factor analysis of variance. Comparisons between 
groups were tested by LSD, P<0.05 were considered to be 
significant. The data was analyzed with SPSS 10. 0 software 
(SPSS Inc., Chicago, IN) and GraphPad 5.0. Image J software 
was used to analysis westernblot semiquantitatively. 
3. Results
3.1. siRNA screening results
  siRNA screening results were as shown in Table 1. Western 
blot test found siRNA 005 and 008 sequence 80 nmol/L could 
significantly inhibit the expression of human SKOV3 cells 
HE4,and the 80 nmol/L HE4-siRNA had the best interference 
effect.
3.2. Construction of long-term interference vectors and viral 
packaging
  Double enzyme digestion was conducted for the plasmids, 
three plasmids could be digested by the Xho 栺,but can not 
be digested by the Hpa栺. The preliminary identification 
of its function showed the construction was successful, 
sequencing for the further identification.
3.3. Identification of silencing of HE4
  After 3 d of HE4 immunoblotting infected cells, western 
blot was used to analyze the efficiency of long-term 
interference. Western blot analysis showed the comparison 
between the interference group and control group, HE4 
protein expression was remarkably decreased (Figure 1).
  Sequence 5, 8 had the knockdown effect, and 5 was better. 
siM was the control cell. Two belts were detected by HE4 
antibody, in which the larger strip was highly glycosylated, 
while the smaller stripe was with lesser extent of 
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glycosylation. From the Figure 1, No 5, 8 si-RNA sequence 
had the best knockdown effect, so they were selected for the 
successive test.
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Figure 1.  RT - PCR, Q-PCR and Western blot identification of 
silencing HE4.
1, SKOV3: untreated SKOV3; 2, SKOV3-mock: empty vector SKOV3; 
3-9, small interfering strains (SKOV3-HE4-si ): SKOV3 transfected 
HE4 small interfering RNA group.
3.4. Change of the biological behavior of SKOV3 cells after 
HE4 silencing proliferation 
  The differences between the knockdown group and controls 
were statistically significant (P=0.021) (Figure 2). Stable HE4 
silencing induced statistically significant inhibition in cell 
proliferation of SKOV3 (13.42%, 23.13%, 26.21%, 33.23%, 
41.21% a at 24-120 h, respectively) for si-HE45 and (12.26%, 
21.13%, 27.28%, 31.32%, 39.89% a at 24-120 h, respectively) 
si-HE48 (Figure 2) (P <0.01). Cells on the third day was 
determined by proliferation cell nuclear antigen (PCNA) 
by Western blot (Figure 3). These results were consistent 
with the MTT results, which indicated that silencing HE4 
significantly inhibited ovarian cancer cells growth in vitro 
and HE4 gene got involved in the regulation of proliferation.
0.75
0.50
0.25
0.00
O
D
49
0
1
2
3
4
0     24   48    72   96  120  144
culturing time (h)
1
2
3
4
0.8
0.6
0.4
0.2
0.0
O
D
49
0
culturing time (h)
24       48.   72    96    120
Figure 2. Cell growth curve after HE4 silencing.
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Figure 3. PCNA after HE4 silencing by Western blot.
1, SKOV3: untreated SKOV3; 2, SKOV3-mock: empty vector SKOV3; 
3, SKOV3-HE4-si 5: SKOV3 transfected HE4 small interfering RNA 
group (No. 5); 4, SKOV3-HE4-si 8: SKOV3 transfected HE4 small 
interfering RNA group (No. 8).
3.5. Apoptosis
  Ratio of early apoptotic cells were as follows: (11.91依2.33)% 
for Si-HE45 and (9.90依2.31)% for Si-HE48. As compared to 
the control: (3.70依1.51)% for untreated SKOV3 group and (6.60
依0.80)% for SKOV3 empty vector group (P<0.01), suggesting a 
increasing early apoptosis (Figure 4).
Table 1 
siRNA oligonucleotide sequences for the human WFDC2 (HE4) gene.
siRNA sequence
si1 F CCGG CAGATGAAATGCTGCCGCAAT CTCGAG ATTGCGGCAGCATTTCATCTG TTTTTG
R AATTCAAAAA CAGATGAAATGCTGCCGCAAT CTCGAG ATTGCGGCAGCATTTCATCTG
si 2 F CCGGGCTGACCAGAACTGCACGCAACTCGAGTTGCGTGCAGTTCTGGTCAGCTTTTTG
R AATTCAAAAAGCTGACCAGAACTGCACGCAACTCGAGTTGCGTGCAGTTCTGGTCAGC
si 3 F CCGGGTGTCCTGTGTCACTCCCAATCTCGAG ATTGGGAGTGACACAGGACAC TTTTTG
R AATTCAAAAAGTGTCCTGTGTCACTCCCAATCTCGAG ATTGGGAGTGACACAGGACAC
si 4 F CCGGGCACAGGAGCAGAGAAGACTT CTCGAGAAGTCTTCTCTGCTCCTGTGCTTTTTG
R AATTCAAAAAGCACAGGAGCAGAGAAGACTTCTCGAGAAGTCTTCTCTGCTCCTGTGC
si 5 F CCGGGGACAGCGAATGCGCCGACAA CTCGAGTTGTCGGCGCATTCGCTGTCCTTTTTG
R AATTCAAAAAGGACAGCGAATGCGCCGACAACTCGAGTTGTCGGCGCATTCGCTGTCC
si 6 F CCGGAGTGCGTCTCGGACAGCGAATCTCGAGATTCGCTGTCCGAGACGCACT  TTTTTG
R AATTCAAAAAAGTGCGTCTCGGACAGCGAATCTCGAG ATTCGCTGTCCGAGACGCACT
si 7 F CCGG GCTCTCTGCCCAATGATAATT CTCGAG AATTATCATTGGGCAGAGAGC  TTTTTG
R AATTCAAAAAGCTCTCTGCCCAATGATAATT CTCGAG  AATTATCATTGGGCAGAGAGC
si 8 F CCGGCCGCAATGGCTGTGGGAAGGTCTCGAGACCTTCCCACAGCCATTGCGG  TTTTTG
R AATTCAAAAACCGCAATGGCTGTGGGAAGGTCTCGAG ACCTTCCCACAGCCATTGCGG
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  Ratio of late apoptotic cells were: (7.21依2.31)% for Si-HE45 
and (5.42依1.92)% for Si-HE48. As compared to the control: 
(6.41依1.23)% for untreated SKOV3 group and (4.78依1.37)% 
for SKOV3 empty vector group (P>0.05), suggesting a similar 
late apoptosis (Figure 4). Our results indicate that HE4 may 
mediate early cell apoptosis.
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Figure 4. Apoptosis analysis by flow cytometry.
1, Untreated SKOV3 group; 2, SKOV3-mock: SKOV3 empty vector 
group; 3, SKOV3-HE4-sh: SKOV3 transfected HE4 small interfering 
RNA.(Si. 5); 4, SKOV3-HE4-sh: SKOV3 transfected HE4 small 
interfering RNA (Si. 8).
3.6. Cell cycle
  HE4 silencing significantly increased the ratio of cells 
in G0/G1 phase and decreased the number of cells in the S 
phase in SKOV3.G0/G1 ratio: (63.26依7.94)% for Si-HE45 and 
(83.36依9.52)% for Si-HE48 as compared to the control: (32.41
依7.14)% for untreated SKOV3 group and (34.25依8.11)% for 
SKOV3 empty vector group (P<0.01), suggesting a G0/G1 arrest 
of the cell cycle (Figure 5).
  S ratio: (29.26依4.34)% for Si-HE45 and (21.42依5.95)% for 
Si-HE48 as compared to the control: (65.41依7.25)% for 
untreated SKOV3 group and (61.25依6.46)% for SKOV3 empty 
vector group (P<0.01), suggesting a block in the G1/S phase 
transition of the cell cycle (Figure 5).
  This indicated that HE4 may mediate cell-cycle regulation 
by promoting the G0-G1 phase transition.
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Figure 5.  Cell cycle analysis by flow cytometry.
1, Untreated SKOV3 group; 2, SKOV3-mock: SKOV3 empty vector 
group; 3, SKOV3-HE4-sh: SKOV3 transfected HE4 small interfering 
RNA.(Si. 5); 4, SKOV3-HE4-sh: SKOV3 transfected HE4 small 
interfering RNA (Si. 8).
3.7. Invasion and migration
  Invasion test:The cell number of SKOV3 single cultured 
group which penetrated Matrigel and reached the lower 
layer of the membrane was (27.0依4.2), the empty vector 
group were(26.0依4.3), while siRNA-HE4 were (14.0依2.7) 
and (15.0依3.1), with significant difference between them 
(P<0.01). Multiple comparison showed that the invaded cell 
numbers in the HE4 low expression group were less than the 
SKOV3 single cultured group and the SKOV3 empty vector 
group (P<0. 01), no difference was found between the single 
cultured group and the SKOV3 empty vector group of the 
invaded cell numbers (P>0.05) (Figure 6), which indicated 
that silencing HE4 lead to impaired capability of invasion of 
SKOV3 cells. 
  Migration test: The cell number of SKOV3 single cultured 
group which penetrated Matrigel and reached the lower 
layer of the membrane was (37.0依5.1), the empty vector 
group were (36.0依5.6), while The siRNA-HE4 were (24.0依
4.5) and (25.0依5.3) with significant difference between them 
(P<0.01). Multiple comparison showed that the invaded cell 
numbers in the HE4 low expression group were less than the 
SKOV3 single cultured group and the SKOV3 empty vector 
group(P<0.01), no difference was found between the single 
cultured group and the SKOV3 empty vector group of the 
invaded cell numbers(P>0.05) (Figure 7), which indicated 
that silencing HE4 lead to decreased capability of migration 
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of SKOV3 cells.
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Figure 6. Cell  invasion test (100×).
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Figure 7.  Cell migration test (100 ×).
1, Untreated SKOV3 group; 2, SKOV3-mock: SKOV3 empty vector 
group; 3, SKOV3-HE4-sh: SKOV3 transfected HE4 small interfering 
RNA.(Si. 5); 4, SKOV3-HE4-sh: SKOV3 transfected HE4 small 
interfering RNA (Si. 8).
3.8. SKOV3 cell protease expression and ERK pathway 
protein after HE4 siliencing
  We investigated protease which were are correlated in 
aggressive serous ovarian carcinoma tissue (Matrix metallo 
proteinases as MMP-9, MMP-2; cathepsin as cathepsin 
B, C; plasminogen-plasmin system as tPA, uPA), and 
significant change of protease protein was observed in HE4 
transfectants compared with control cells. Silencing HE4 
caused marked and significant reduction in MMP-9, MMP-2 
and cathepsinB transcription in siHE4 SKOV3 cells, about 
(38.0依8.2)% decrease in MMP-9, (45.0依7.6)% decrease in 
MMP-2 and (52.0依8.3)% decrease in cathepsin B (Figure 8), 
though tPA ,uPA, cathepsin C remained similar compared to 
control (data not shown).
  Proteins involed in ERK pathway as phosphorylated protein 
as P-EGFR, p- ERK also decreased after HE4 siliencing 
(Figure 9).
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Figure 8. SKOV3 cell protease expression after HE4 siliencing.
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Figure 9. Change of ERK pathway protein after HE4 siliencing.
1, Untreated SKOV3 group; 2, SKOV3-mock: SKOV3 empty 
vector group; 3, SKOV3-HE4-sh: SKOV3 transfected HE4 
small interfering RNA (Si. 5); 4, SKOV3-HE4-sh: SKOV3 
transfected HE4 small interfering RNA (Si. 8).
    
4.  Discussion
  Human epididymal secretory protein 4(HE4) is a new 
and promising marker for ovarian cancer[2] and it was 
regarded to be encoded by WFDC2 gene. Results from the 
OVCAD study found that preoperative HE4 expression in 
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plasma predicts surgical outcome in primaryovarian cancer 
patients. hereby, we speculated that HE4 gene might plays 
an important role in the occurring and developing of the 
serous ovarian cancer. So clarifying WFDC2 gene function 
may help us to identify a new therapeutic target in ovarian 
cancer. Unfortunately, the function of WDC2 gene in ovarian 
cancer is remained unclarified. In this study, we tried to 
investigate effect of silencing human WFDC2 (HE4) gene on 
biological behavior changes as cell proliferation,apoptosis, 
movement and invasion of human serous ovarian cancer cell 
line SKOV3 and the possible mechanisms.
  After silencing HE4 gene, there were changes on the 
proliferation, apoptosis, migration and invasion ability of the 
ovarian carcinoma SKOV3 cell strain, and was accompanied 
by the change of the relevant cell pathway of ERK. 
Therefore, we concluded that the HE4 gene was involved 
in the regulation of ovarian cancer biological behavior, 
which is consistent with the clinical study of the serum HE4 
ovarian cancer prognosis.  
  In this study, we found that the ability of proliferation of 
SKOV3 significantly impaired after silencing HE4 gene, 
suggesting that HE4 involved in the regulation of ovarian 
serous carcinoma proliferation. This is consistent with the 
report that WFDC2 genes were involved in the mediation of 
ovarian cancer proliferation and apoptosis genes[8]. From 
the structural analogy, the HE4 protein precursor 32 to 73, 
76 to 123 amino acids forming two characteristic whey acid 
protein (whey acidic protein, WAP) domain and it belongs 
to the disulfide-core (4-DSC) family. Therefore, the HE4 
the protein is considered to be the encoding product of the 
WFDC2 gene, which is a secreted protein characterized by 
acidic, small single signal peptide and the cysteine-rich 
polypeptide, is a member in the lactic protein (WAP) domain 
family.
  Epidermal growth factor receptor (epidermalgrowch factor 
receptor, EGFR)[9] is a transmembrane receptors which gene 
encoding by C-erbBl and having protein tyrosine kinase 
(receptor tyrosine kinase RTK) activity. EGFR were composed 
of three parts, which were extracellular ligand binding 
domain, transmembrane domain and the intracellular region. 
The intracellular region is the important parts which can play 
a key role in tyrosine kinase activity and mediated signal 
transduction. EGRF widely expressed in human epidermal 
cells and stromal cells. Studies have been reported in recent 
years that the EGFR signaling pathway were mostly in closed 
state of in normal tissues, and is opened after activated in 
tumor tissue. That was close related to the proliferation of 
the tumor, the downstream signal transduction pathways 
of it including Ras-ERK/MAPK, PI3K/AKT and JAK/STAT. 
Extracellular signal-regulated protein kinase (extracellular-
signal regulated protein kinase, ERK) is an important signal 
transduction protein kinases which introduce extracellular 
signals by eukaryotic cell into the intracellular reactions, 
and it regulate a variety of processes including cell growth, 
differentiation, migration and invasiona. Clinical studies 
have shown that there was overexpression of EGFR and ERK 
in ovarian cancer, and EGRF antibody plays an important 
role in the treatment of ovarian cancer[10]. In this study, The 
ERK and EGFR phosphorylation levels were significantly 
lower after knockdown HE4. This suggests HE4 may inhibite 
the information of ERK/MAPK downstream signaling 
pathways of EGFR to inhibit the growth of SKOV3.
  Caspase-3 normally exists in cytoplasm in the form of 
a zymogen (32KD), it is activated in the early stages of 
apoptosis.The activated Caspase-3 is composed of two 
large subunits (17KD) and two small subunit (12KD), the 
corresponding cytoplasm nucleus substrate cleavaged, 
eventually leading to apoptosis. Caspase-3 activation is 
often used as an important indicator of apoptosis. Western 
blot analysis the activation of the Procaspase-3, as well as 
the cleavage of the substrate poly (ADP-ribose) polymerase 
[poly (ADP-ribose) polymerase, PARP] by the activated 
Caspase-3. Western blot detected the cleavage of caspase 
and the changes of p-Akt expression level. Caspase family 
plays a very important role in the process of mediating 
apoptosis, and caspase-3 is a critical execution molecules, 
which is functional in many pathways of the apoptosis signal 
transduction.
  In our study, although the flow cytometry showed slightly 
increased early apoptosis ratio in the SKOV3-HE4-si group, 
1) There was no difference of late apoptosis ratio between 
groups; 2)the absolute change of early apoptosis ratio are less 
than 5%, which is a small probability event; 3)westernblot of 
Caspase-3 and Bcl-2 proteins which were activated in the 
early stages of apoptosis failed to show any change between 
groups(data not shown). Therefore it indicated that the effect 
of HE4 gene on early apoptosis should be further explored; 
or it implied that HE4 may affect apoptosis through other 
means such as the mitochondrial pathway rather traditional 
Fas/FasL apoptosis pathway.
  The study found after silenced HE4 gene, the expression 
of proteinases (MMP-9, cathepsinB) on SKOV3 cells was 
reduced, which may explain the change of the invasion 
force.Proteinases play an important role in the invasion of 
in tumors including the ovarian cancer[11]. Invasion and 
metastasis is a direct cause of death for patients with ovarian 
cancer. By degradation of the extracellular matrix (ECM), 
matrix metalloproteinases (MMPs) play an important role in 
the invasion and metastasis of ovarian cancer. Cathepsin 
is an acidic cysteine proteases exists in lysosomes of all 
cells, it promote tumor invasion through the degradation 
of collagen, elastin, laminin, and other components of the 
extracellular matrix. WFDC2, encodes for a13-kDa protein. 
Its mature 25-kDa glycosylated form consists of a single 
peptide and two whey acidic protein (WAP) domains that 
contain a ’’four disulfide core’’ composed of eight cysteine 
residues. The gene is located on human chromosome 20q12-
13.1, a region that includes several genes that encode 
WAP domain proteins[12]. The WAP architecture domain 
has an inhibitory ring structure,which can be inserted into 
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the structural region of the protease activity to inhibit the 
proteases,and has a certain homology with HE4. human 
leukocyte protease inhibitor SLPI and lung elastase inhibitor 
elafin.,members of WAP family including SLPI, Elafin,which 
characteristics of having a strong protease inhibitor[13]. 
From point of molecular structure, HE-4, is also a member 
of WAP family with with two WFDC domains.The WAP 
architecture domain has an inhibitory ring structure, which 
can be inserted into the protease activity structure area to 
inhibiting protease. While HE4 WAP architecture contains 
two domains, which have some homology with elafin and 
SLPI, it is a new type of protease inhibitor[14]. Therefore 
we inferred that HE4 may involved in tumor cell invasion 
through protease.
  In summary, after silencing HE4 gene, serous ovarian 
carcinoma SKOV3 cell strain changed on proliferation, 
apoptosis, migration and invasion ability, and was 
accompanied by the change of the the relevant mechanism. 
Therefore, we concluded that the HE4 gene were involved 
in the regulation of ovarian cancer biological behavior, 
which is consistent with the clinical study of serum HE4 and 
ovarian cancer prognosis. HE4 may be a new target for the 
treatment of ovarian cancer.
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